Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Yiting Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9928-2487; OpenAlex author ID A5101429265. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Preoperative prediction of early recurrence in pancreatic cancer: A novel clinical-radiomics model. Co-author DOI 10.1002/ijc.70142↗
  2. MTFP1 drives pancreatic cancer liver metastatic colonisation by regulating mitochondrial metabolism reprogramming. Co-author DOI 10.1136/gutjnl-2025-336323↗
  3. Integrating Body Composition and Nutritional Indices: A Novel Prognostic Tool for Survival in Pancreatic Cancer. Co-author DOI 10.1002/jcsm.70006↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qi Zhang · 2 shared papers, 2025–2026 · strength 0.47
  2. Tingbo Liang · 2 shared papers, 2025–2026 · strength 0.47
  3. Xu Han · 1 shared paper, 2026 · strength 0.24
  4. Yang Chen · 1 shared paper, 2026 · strength 0.24
  5. Yunhua Liu · 1 shared paper, 2026 · strength 0.24
  6. Qi Zhang · 1 shared paper, 2026 · strength 0.24
  7. Tingbo Liang · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.